Related Experiment Videos
Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys
Abstract:
Systemic administration of the recently discovered neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) produces severe clinical parkinsonism and degeneration of the substantia nigra in humans and monkeys. In previous studies, no convincing structural damage to nerve cells outside the substantia nigra could be demonstrated in subhuman primates. Using a protracted MPTP regimen and older animals, we now report locus ceruleus lesions and eosinophilic inclusion bodies in squirrel monkeys. The inclusions were seen only in areas where Lewy bodies are found in human Parkinson's disease. No such abnormalities were seen in control animals. These findings suggest that similarities between the neuropathology of MPTP-induced parkinsonism in the monkey and human Parkinson's disease are greater than first thought and increase the usefulness of the MPTP monkey model for research in Parkinson's disease.
Insights
Systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) causes parkinsonism. New findings reveal MPTP also damages the locus ceruleus and forms inclusion bodies in monkeys, mirroring human Parkinson's disease pathology.
Area of Science:
- Neuroscience
- Toxicology
- Neuropathology
Background:
- 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a neurotoxin causing parkinsonism.
- Previous research indicated MPTP primarily affects the substantia nigra, with limited extranigral damage in primates.
Purpose of the Study:
- To investigate the extranigral neuropathological effects of a protracted MPTP regimen in older squirrel monkeys.
- To compare MPTP-induced lesions with neuropathological hallmarks of human Parkinson's disease.
Main Methods:
- Squirrel monkeys received a protracted regimen of MPTP.
- Histopathological examination focused on extranigral brain regions, particularly the locus ceruleus.
- Inclusion bodies were characterized and compared to Lewy bodies in human Parkinson's disease.
Main Results:
- Protracted MPTP administration induced lesions in the locus ceruleus of squirrel monkeys.
- Eosinophilic inclusion bodies, similar to Lewy bodies, were observed in MPTP-treated animals.
- No such neuropathological abnormalities were found in control animals.
Conclusions:
- MPTP-induced parkinsonism in monkeys exhibits greater neuropathological similarity to human Parkinson's disease than previously recognized.
- The findings enhance the utility of the MPTP monkey model for studying Parkinson's disease mechanisms and potential therapies.